Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.
Shimazu, Kazuhiro
Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors. [electronic resource] - Cancer science Oct 2018 - 3285-3293 p. digital
Publication Type: Journal Article
1349-7006
10.1111/cas.13741 doi
Angiogenesis Inhibitors--pharmacology
Animals
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Curcumin--analogs & derivatives
Drug Resistance, Neoplasm--drug effects
Fibronectins--genetics
Gene Knockdown Techniques
Human Umbilical Vein Endothelial Cells--drug effects
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasms--blood supply
Neovascularization, Pathologic--drug therapy
RNA, Small Interfering--metabolism
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Xenograft Model Antitumor Assays
Xenopus laevis
Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors. [electronic resource] - Cancer science Oct 2018 - 3285-3293 p. digital
Publication Type: Journal Article
1349-7006
10.1111/cas.13741 doi
Angiogenesis Inhibitors--pharmacology
Animals
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Curcumin--analogs & derivatives
Drug Resistance, Neoplasm--drug effects
Fibronectins--genetics
Gene Knockdown Techniques
Human Umbilical Vein Endothelial Cells--drug effects
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasms--blood supply
Neovascularization, Pathologic--drug therapy
RNA, Small Interfering--metabolism
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Xenograft Model Antitumor Assays
Xenopus laevis